Virax Biolabs Group Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2024-09-30 |
|---|---|---|---|
Revenue | $1 | $1 | $4 |
Gross Profit | -215 | -46 | -6 |
EBITDA | -2,369 | -3,139 | -2,766 |
EBIT | -2,585 | -3,284 | -2,878 |
Net Income | -2,338 | -3,304 | -2,756 |
Net Change In Cash | 1 | 1 | 4 |
Free Cash Flow | -3,064 | -3,000 | -2,166 |
Cash | 3,345 | 4,228 | 7,285 |
Basic Shares | 4,763 | 4,357 | 3,103 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $6 | $156 | $8 | $0 |
Gross Profit | -53 | 50 | -1 | 0 |
EBITDA | -5,802 | -6,609 | -5,442 | |
EBIT | -6,145 | -6,712 | -5,442 | -1,734 |
Net Income | -6,061 | -6,733 | -5,457 | -1,708 |
Net Change In Cash | 6 | 156 | 8 | 0 |
Free Cash Flow | -5,167 | -7,411 | -4,358 | -809 |
Cash | 4,228 | 3,589 | 9,352 | 21 |
Basic Shares | 3,103 | 2,006 | 1,062 | 1,137 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.49 |
2025-06-30 | -$0.76 |
2024-09-30 | -$0.89 |
2022-06-30 | -$0.03 |
